Novartis Investigative Site

Torono, Ontario M5G 2C4

0 studies enrolling now · 4 studies all time

What they study most

Hepatitis C, Hepatitis C, Chronic, Lymphangioleiomyomatosis (LAM), Polymyositis, Tuberous Sclerosis Complex (TSC)

Studies at this site

• Efficacy and Tolerability of BAF312 in Patients With Polymyositis — Stopped early
• 3-year Follow-up Study to Assess the Viral Activity in Hepatitis C Patients Who Failed Feeder DEB025/Alisporivir Study — Stopped early
• Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM) — Completed
• Long Term Follow-up Study to Assess Durability of Sustained Virologic Response in Alisporivir-treated Hepatitis C Patients — Completed